Clinical Trials List
2024-06-28 - 2028-05-31
Phase III
Not yet recruiting3
Recruiting4
ICD-10C76.0
Malignant neoplasm of head, face and neck
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9195.0
Malignant neoplasm of other and ill-defined sites of head, face and neck
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Tsung-Jang Yeh Division of Hematology & Oncology
- 王閔宏 Division of Hematology & Oncology
- 高育青 Division of Hematology & Oncology
- Jeng-Shiun Du Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Pei-Jen Lou Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- RUEY-LONG HONG Division of Hematology & Oncology
- YA-FANG CHEN Division of Radiology
- 黃彥霖 Division of Hematology & Oncology
- 楊明翰 Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ching Yun Hsieh Division of Hematology & Oncology
- Yu-Min Liao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 王全正 Division of Hematology & Oncology
- 石宇閎 Division of Hematology & Oncology
- 凃政宏 Division of Otolaryngology
- 楊繕駿 Division of Radiation Therapy
- 林炫聿 Division of Hematology & Oncology
- 余萬年 Division of Otolaryngology
- 何宇傑 Division of Radiation Therapy
- 賴冠銘 Division of Hematology & Oncology
- 謝明妤 Division of Otolaryngology
- 林振斌 Division of Radiation Therapy
- 曾若涵 Division of Hematology & Oncology
- 蔡昌益 Division of Otolaryngology
- 凃智文 Division of Otolaryngology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 廖俊達 Division of Otolaryngology
- Chi-Ting Liau Division of Hematology & Oncology
- Li-Yu Lee Division of Others -
- Cheng-Lung Hsu Division of Hematology & Oncology
- 葉智華 Division of Radiology
- Chia-Hsun Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Mu-Hsin Chang Division of Hematology & Oncology
- Tien-Hua Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃泰霖 Division of Hematology & Oncology
- 劉建廷 Division of Hematology & Oncology
- 林昶廷 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- 林偉哲 Division of Radiology
- Yu-Li Su Division of Hematology & Oncology
- 黃詩喻 Division of Hematology & Oncology
- 李易濰 Division of Radiology
- 陳彥豪 Division of Hematology & Oncology
- 郭明濬 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
45 participants
-
Global
500 participants
